Dianthus Therapeutics (DNTH) Assets Growth (1y) (2018 - 2025)
Dianthus Therapeutics (DNTH) Assets Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Dianthus Therapeutics | 3.92 Bn | 3.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 41.95% |
| Sep 30, 2025 | 63.01% |
| Jun 30, 2025 | -11.62% |
| Mar 31, 2025 | -8.86% |
| Dec 31, 2024 | 108.47% |
| Sep 30, 2024 | 84.06% |
| Jun 30, 2024 | 369.19% |
| Mar 31, 2024 | 358.36% |
| Dec 31, 2023 | 115.86% |
| Sep 30, 2023 | 17.27% |
| Jun 30, 2023 | -55.10% |
| Mar 31, 2023 | -57.07% |
| Dec 31, 2022 | -56.24% |
| Sep 30, 2022 | -20.42% |
| Jun 30, 2022 | -20.54% |
| Mar 31, 2022 | 34.41% |
| Dec 31, 2021 | 17.52% |
| Sep 30, 2021 | 18.09% |
| Jun 30, 2021 | 15.55% |
| Mar 31, 2021 | 0.12% |